Explore the Global Parasomnia Treatment Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Parasomnia Treatment Market

Key Insight

FMI opines the parasomnia treatment market was valued at USD 343.10 million in 2025. Sales are expected to reach USD 360.94 million in 2026 and USD 599.23 million by 2036. Non-Rapid Eye Movement is poised to lead by Type with 45.0% share in 2026 and Benzodiazepines is estimated to command by Treatment Type in 2026.

April 10, 2026

Anurag Sharma

275 Pages

Cite this Report

Parasomnia Treatment Market

https://www.futuremarketinsights.com/reports/parasomnia-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Aurobindo Pharma
Cadila Pharmaceuticals Ltd
Intas Pharmaceuticals Ltd
The Vanguard Group
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway
Torrent Pharmaceuticals Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Parasomnia Treatment Market

Key Players

Similar Industry Reports